#VetDC

Drug to treat canine lymphoma gets FDA approval

Drug to treat canine lymphoma gets FDA approval

January 3, 2017

VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
New on
VPN Plus+

Join VPN Plus+ today to get access to exclusive content like:

Mental health as One Health
Mental health as One Health
Have You Tried This Yet? New (or New-ish) Products, Protocols and Procedures in Veterinary Anesthesia and Analgesia
Have You Tried This Yet? New (or New-ish) Products, Protocols and Procedures in Veterinary Anesthesia and Analgesia
Think 'standard of caring,' not 'standard of care'
Think 'standard of caring,' not 'standard of care'
No Pain is More Gain: Multimodal Analgesia in Dogs and Cats
No Pain is More Gain: Multimodal Analgesia in Dogs and Cats
Join Now!
VPN Plus+ Store